Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-292985

Chief Executive Officer sold 49,666 shares at $240.25 ($11,932,257)

  • Chief Executive Officer acquired 49,666 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TABUTEAU HERRIOT Chief Executive Officer 2026-07-01 Option exercise 10b5-1 +49,666 $4.95 $245,847 56,895 D
TABUTEAU HERRIOT Chief Executive Officer 2026-07-01 Sale 10b5-1 −49,666 $240.25 $11,932,257 7,229 D
Derivatives
TABUTEAU HERRIOT Chief Executive Officer 2026-07-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −49,666 49,664 D
Open-market sales · 49,666 sh · avg $240.25 · $11,932,257
Loading xslF345X06/ownership.xml…